<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163420</url>
  </required_header>
  <id_info>
    <org_study_id>CEBC-CU-2016-10-149</org_study_id>
    <nct_id>NCT03163420</nct_id>
  </id_info>
  <brief_title>Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis</brief_title>
  <official_title>Effect of Pre-operative Diclofenac Potassium on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Cases With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to evaluate the effect of pre-operative administration of
      diclofenac potassium on the efficacy of inferior alveolar nerve block on using 2% mepivacaine
      anaesthetic agent in patients with symptomatic irreversible pulpitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The aim of this clinical trial is to evaluate the effect of pre-operative
      administration of diclofenac potassium on the efficacy of inferior alveolar nerve block on
      using 2% mepivacaine anaesthetic agent in patients with symptomatic irreversible pulpitis.

      Design: Randomized double-blind controlled trial.

      Setting and conduct:

        -  Patients source: Out patients of the clinic of Endodontics at the Faculty of Oral and
           Dental Medicine, Cairo University.

        -  Patients will be clinically and radiographically examined and their eligibility will be
           assessed and preoperative pain will be measured. Eligible patients will be treated in
           one visit.

        -  Patients will be randomly assigned to one of 2 groups: experimental group (taking a 50
           mg diclofenac potassium packet) and the control group (taking a placebo packet). Each
           packet will be taken 30 minutes before starting treatment. The patient's pain will be
           assessed before local anesthetic administration using Heft- Parker Visual Analog Scale
           (HP- VAS). . After 15 minutes of the initial inferior alveolar nerve block (IANB) of 1.8
           ml of 2% mepivacaine hydrochloride with 1:100000 epinephrine, the teeth will be examined
           using a cold pulp sensitivity test; in case of lip numbness together with no or mild
           pain on cold, the treatment will be initiated.

        -  During root canal treatment, no to mild pain response on HP- VAS will be considered
           success. In case of failure, supplemental anesthesia will be administered.

        -  Main outcome measures: Anesthetic success during root canal treatment using HP VAS.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anesthetic success</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Pain during treatment is measured using Heft Parker VAS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain on injection of initial IANB</measure>
    <time_frame>Intraoperative</time_frame>
    <description>measured using Heft Parker VAS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac potassium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diclofenac potassium 50 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac potassium</intervention_name>
    <description>Diclofenac potassium 50 mg granules for oral solution</description>
    <arm_group_label>Diclofenac potassium</arm_group_label>
    <other_name>Catafast-Novartis International AG, Basel, Switzerland</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Fructose</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients in good health as determined by a medical history and oral questioning. (ASA
             I or II)

          2. Age range is between 18 and 50 years.

          3. Patients having symptomatic irreversible pulpitis in one of their mandibular molars.

          4. Patients who can understand Heft Parker Visual Analogue Scales VAS.

          5. Patients accepting to participate in the study and able to sign informed consent.

        Exclusion Criteria:

          1. Pregnant female patient.

          2. Patients allergic to diclofenac potassium or mepivacaine.

          3. Patients having active pain in more than one mandibular molar.

          4. Patients who had taken analgesics in the 12 hours preceding the injection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled M Ezzat, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Oral and Dental medicine, Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suzan AW Amin, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Oral and Dental medicine, Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Oral and dental medicine, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Prasanna N, Subbarao CV, Gutmann JL. The efficacy of pre-operative oral medication of lornoxicam and diclofenac potassium on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a double-blind, randomised controlled clinical trial. Int Endod J. 2011 Apr;44(4):330-6.</citation>
    <PMID>21692235</PMID>
  </reference>
  <reference>
    <citation>Shetkar P, Jadhav GR, Mittal P, Surapaneni S, Kalra D, Sakri M, Basavaprabhu A. Comparative evaluation of effect of preoperative alprazolam and diclofenac potassium on the success of inferior alveolar, Vazirani-Akinosi, and Gow-Gates techniques for teeth with irreversible pulpitis: Randomized controlled trial. J Conserv Dent. 2016 Sep-Oct;19(5):390-5. doi: 10.4103/0972-0707.190013.</citation>
    <PMID>27656053</PMID>
  </reference>
  <reference>
    <citation>Saha SG, Jain S, Dubey S, Kala S, Misuriya A, Kataria D. Effect of Oral Premedication on the Efficacy of Inferior Alveolar Nerve Block in Patients with Symptomatic Irreversible Pulpitis: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. J Clin Diagn Res. 2016 Feb;10(2):ZC25-9. doi: 10.7860/JCDR/2016/16873.7195. Epub 2016 Feb 1.</citation>
    <PMID>27042580</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>May 20, 2017</last_update_submitted>
  <last_update_submitted_qc>May 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Aya Ahmed Youssef</investigator_full_name>
    <investigator_title>Postgraduate student</investigator_title>
  </responsible_party>
  <keyword>Anesthetic efficacy</keyword>
  <keyword>Diclofenac</keyword>
  <keyword>Irreversible pulpitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

